Compounds > 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin
Page last updated: 2024-09-05

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Carcinoma, Oat Cell

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with Carcinoma, Oat Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Vries, EG; Meijer, C; Mulder, NH; van der Graaf, WT1
Coley, HM; Twentyman, PR; Workman, P1

Other Studies

2 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Carcinoma, Oat Cell

ArticleYear
The role of methoxymorpholino anthracycline and cyanomorpholino anthracycline in a sensitive small-cell lung-cancer cell line and its multidrug-resistant but P-glycoprotein-negative and cisplatin-resistant counterparts.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Resistance; Drug Resistance, Multiple; Humans; Lung Neoplasms; Tumor Cells, Cultured

1995
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:6

    Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Neoplasm Proteins; Tumor Cells, Cultured

1990